MindMaze Therapeutics Holding SA (RLFTF)
OQB
Closing price as of 2026-07-28 · Source: TEK2day Finance
Key Metrics
About MindMaze Therapeutics Holding SA
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
Annual Financials
| Metric | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 3.3M | 6.1M | 6.0M | 8.4M |
| Gross Profit | -16.5M | 4.8M | 4.3M | 5.8M |
| Operating Income | -34.6M | -35.5M | -19.8M | -7.9M |
| Net Income | -34.7M | -50.8M | -98.2M | -17.1M |
| Diluted EPS | $-4.00 | $-4.80 | $-8.35 | $-1.36 |